Deliang Guo

7PUBLICATIONS
36CO-AUTHORS
Cancer cell biologyMolecular targetsSeparation technologiesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 28, 2026
SREBP-1 increases glucose uptake to promote tumor resistance to lysosome inhibition.

Yaogang Zhong, Feng Geng, Huali Su

|Apr 18, 2025
Targeting PGM3 abolishes SREBP-1 activation-hexosamine synthesis feedback regulation to effectively suppress brain tumor growth.

Huali Su, Yaogang Zhong, Liqing He

|Sep 02, 2024
Tumor cells utilize acetate for tumor growth and immune evasion.

Peng Sun, Juanjuan Liu, Deliang Guo

|May 31, 2024
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity.

Chandra Bhushan Prasad, Adrian Oo, Yujie Liu

|May 09, 2022
Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth.

Chunming Cheng, Feng Geng, Zoe Li

|Jan 20, 2022
Targeting Squalene Epoxidase Interrupts Homologous Recombination via the ER Stress Response and Promotes Radiotherapy Efficacy.

Zhipeng Hong, Tao Liu, Lingfeng Wan

Pageof 2

Frequent Collaborators

3 joint publications

Feng Geng

3 joint publications

Qi-En Wang

3 joint publications

Xiaokui Mo

3 joint publications

Junran Zhang